Cardiorespiratory responses to intracerebroventricular injection of neuropeptide Y in anaesthetised dogs

Regulatory Peptides

Volumn 81, Issue 1-3, 1999, Pages 81-88

  Morton, K D R ^a   McCloskey, M J D ^a   Potter, E K ^a  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Blood pressure; Brain; Heart rate; NPY antagonist; NPY Y1 agonist; Ventilation

Indexed keywords

ATROPINE; GR 231118; NEUROPEPTIDE Y; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BREATHING; CARDIOVASCULAR RESPONSE; DOG; FEMALE; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; DOGS; FEMALE; HEART RATE; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RECEPTORS, NEUROPEPTIDE Y; RESPIRATION; VENTILATION;

CANIS FAMILIARIS;

EID: 0033038366     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00021-X     Document Type: Article

References (40)

1. O'Donohue T.L., Chronwall B.M., Pruss R.M., Mezey E., Kiss J.Z., Eiden L.E., Massari V.J., Tessel R.E., Pickel V.M., DiMaggio D.A. Neuropeptide Y and peptide YY neuronal and endocrine systems. Peptides. 6:1985;755-768.
2. 2 receptor subtypes in human and rat brain. Brain Res. 631:1993;27-38.
3. 1 mRNA in forebrain areas of the rat central nervous system. Eu. J. Neurosci. 5:1993;1622-1637.
4. 2 receptor radioligands. Synapse. 22:1996;139-158.
5. Gray T.S., Morley J.E. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci. 38:1986;389-401.
6. Martel J.C., St-Pierre S., Quirion R. Comparative distribution of neuropeptide Y immunoreactivity and receptor autoradiography in rat forebrain. Peptides. 9:(Suppl. 1):1988;15-20.
7. Danger J.M., Tonon M.C., Jenks B.G., Saint-Pierre S., Martel J.C., Fasolo A., et al. Neuropeptide Y: localization in the central nervous system and neuroendocrine functions. Fundamental Clin Pharmacol. 4:1990;307-340.
8. Carter D.A., Vallejo M., Lightman S.L. Cardiovascular effects of neuropeptide Y in the nucleus tractus solitarius of rats: relationship with noradrenaline and vasopressin. Peptides. 6:1985;421-425.
9. Macrae I.M., Reid J.L. Cardiovascular significance of neuropeptide Y in the caudal ventrolateral medulla of the rat. Brain Res. 456:1988;1-8.
10. Westfall T.C., Martin J., Chen X.L., Ciarleglio A., Carpentier S., Henderson K., Knuepfer M., et al. Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y. Synapse. 2:1988;299-307.
11. Fuxe K., Aguirre J.A., Agnati L.F., von Euler G., Hedlund P., Covenas R., Zoli M., Bjelke B., Eneroth P. Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neurons. Ann New York Acad Sci. 611:1990;111-132.
12. Aguirre J.A., Fuxe K., Agnati L.F., von Euler G. Centrally injected neuropeptide Y 13-36 produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y 1-36 in the awake male rat. Neurosci. Lett. 118:1990;5-8.
13. Harfstrand A. Brain neuropeptide Y mechanisms. Basic aspects and involvement in cardiovascular and neuroendocrine regulation. Acta Physiol. Scand. Supplementum. 565:1987;1-83.
14. 125I-neuropeptide Y binding sites in the nucleus tractus solitarius of the normal male rat. Acta Physiol. Scand. 128:1986;195-200.
15. McLean K.J., Jarrott B., Lawrence A.J. Neuropeptide Y gene expression and receptor autoradiography in hypertensive and normotensive rat brain. Mol Brain Res. 35:1996;249-259.
16. 3H]BIBP3226. Neuroreport. 7:1996;901-904.
17. Loewy A.D., McKellar S. The neuroanatomical basis of central cardiovascular control. Fed. Proc. 39:1980;2495-2503.
18. 2 receptors for neuropeptide Y in the nucleus of the solitary tract mediate depressor responses. Peptides. 12:1991;691-698.
19. 1 receptor agonist. Brain Res. 621:1993;126-132.
20. McDermott B.J., Millar B.C., Piper H.M. Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc Res. 27:1993;893-905.
21. 34] NPY, a selective functional postjunctional agonist at neuropeptide Y receptors in anaesthetised rats. Neurosci. Lett. 134:1992;183-186.
22. Daniels A.J., Matthews J.E., Slepetis R.J., Jansen M., Viveros O.H., Tadepalli A., Harrington W., et al. High-affinity neuropeptide Y receptor antagonists. Proc Natl Acad Sci USA. 92:1995;9067-9071.
23. 1 receptor antagonist. J Pharmacol Exp Therapeut. 275:1995;1261-1266.
24. 2) receptor. Eur. J. Pharm. 267:1994;253-262.
25. Schneyer K. Zur Frage der Blutdruckcharakteristik. Pflug. Archiv. ges Physiol. 235:1935;176-183.
26. Scott N.A., Webb V., Boublik J.H., Rivier J., Brown M.R. The cardiovascular actions of centrally administered neuropeptide Y. Reg Pept. 25:1989;247-258.
27. Barraco R.A., Ergene E., Dunbar J.C., el-Ridi M.R. Cardiorespiratory response patterns elicited by microinjections of neuropeptide Y in the nucleus tractus solitarius. Brain Res Bull. 24:1990;465-485.
28. Fuxe K., Agnati L.F., Harfstrand A., Zini I., Tatemoto K., Pich E.M., et al. Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol. Scand. 118:1983;189-192.
29. Fuxe K., Harfstrand A., Agnati L.F., Kalia M., Fredholm B., Svensson T., Gustafsson J.A., Lang R., Ganten D. Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers. J Cardiovasc Pharmacol. 10:(Suppl. 12):1987;S1-13.
30. 2 receptor binding in the nucleus tractus solitarius. Brain Res. 684:1995;159-164.
31. Anrep G.V., Pascual W., Rossler R. Respiratory variations of the heart rate-I The reflex mechanism of the respiratory arrhythmia. Proc. Roy. Soc. B. 119:1936;191-229.
32. 4) receptor. Peptides. 19:1998;537-542.
33. 4 receptor agonists. Eur J Pharmacol. 349:(1):1998;97-105.
34. 1 receptors-evidence for heterogeneity in pancreatic polypeptide receptors. Peptides. 18:1997;397-401.
35. Kilborn M.J., Potter E.K., McCloskey D.I. Neuromodulation of the cardiac vagus: comparison of neuropeptide Y and related peptides. Regulatory Peptides. 12:1985;155-161.
36. Chan J.Y., Shih C.D., Chan S.H. Participation of endogenous neuropeptide Y in the suppression of baroreceptor reflex response by locus coeruleus in the rat. Reg. Peptides. 48:1993;293-300.
37. Grundemar L., Wahlestedt C., Reis D.J. Long-lasting inhibition of the cardiovascular responses to glutamate and the baroreceptor reflex elicited by neuropeptide Y injected into the nucleus tractus solitarius of the rat. Neurosci. Lett. 122:1991;135-139.
38. Meeley M.P., Underwood M.D., Talman W.T., Reis D.J. Content and in vitro release of endogenous amino acids in the area of the nucleus of the solitary tract of the rat. J Neurochem. 53:1989;1807-1817.
39. Nakajima M., Inui A., Asakawa A., Momose K., Ueno N., Teranishi A., Baba S., Kasuga M. Neuropeptide Y produces anxiety via Y2-type receptors. Peptides. 19:1998;359-363.
40. Walter M.J., Scherrer J.F., Flood J.F., Morley J.E. Effects of localized injections of neuropeptide Y antibody on motor activity and other behaviors. Peptides. 15:1994;607-613.